Pharis Mohideen is Chief Medical Officer at DBV Technologies S.A. (DBVT). They have made 12 open-market trades across 1 company since 2022, most recently 2026-07-29.
CIK 0001760395
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DBVT | 144,531 | $1.3M |
| MLND | 7,440 | — |
| Total | $1.3M |
Shares reported on the most recent Form 4, priced at the 2026-07-31 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DBVT | SELL | 2026-07-29 | 2026-07-31 | $2.70 | $1K | +6.7% | +4.3% | — |
| DBVT | SELL | 2026-01-29 | 2026-02-02 | $4.86 | $3K | -1.1% | +3.9% | -11.2% |
| DBVT | SELL | 2025-11-20 | 2025-11-25 | $2.86 | $23K | +30.6% | +47.5% | +63.3% |
| DBVT | SELL | 2025-07-29 | 2025-07-31 | $2.22 | $1K | +5.9% | -0.9% | +64.3% |
| DBVT | SELL | 2025-05-22 | 2025-05-27 | $1.84 | $730 | -5.7% | -4.9% | +1.1% |
| DBVT | SELL | 2025-01-30 | 2025-01-31 | $0.85 | $510 | +2.7% | -1.2% | +114.7% |
| DBVT | SELL | 2024-11-22 | 2024-11-27 | $0.55 | $503 | +1.2% | -6.6% | +20.2% |
| DBVT | SELL | 2024-11-21 | 2024-11-25 | $0.54 | $1K | +32.9% | +8.2% | +49.3% |
| DBVT | SELL | 2024-07-29 | 2024-07-31 | $0.98 | $2K | -8.3% | -6.3% | -14.6% |
| DBVT | SELL | 2024-05-22 | 2024-05-29 | $1.37 | $1K | -8.9% | -29.9% | -22.9% |
| DBVT | SELL | 2023-11-22 | 2023-12-19 | $1.74 | $4K | -3.8% | -15.6% | -21.8% |
| DBVT | SELL | 2022-11-24 | 2023-08-14 | $3.02 | $7K | -4.7% | -4.1% | -41.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.